Skip to main content
. Author manuscript; available in PMC: 2019 Nov 1.
Published in final edited form as: Mol Neurobiol. 2018 Mar 18;55(11):8438–8454. doi: 10.1007/s12035-018-1004-1

Table 1. Competitive inhibition experiments of [3H]RX821002 versus NE, DA, clonidine and D2-like receptor ligands in sheep brain cortex and striatum.

LIGAND BINDING PARAMETERS

CORTEX STRIATUM
KDB1: 0.3 ± 0.2 * KDB1: 0.8 ± 0,1
NE KDB2: 250 ± 100 KDB2: 5000 ± 3000
DCB: -2.3 DCB: -3.2

KDB1: 6.9 ± 0.2 KDB1: 6 ± 1
DA KDB2: 350 ± 10 * KDB2: 1000 ± 200
DCB: -1.1 DCB: -1.6

KDB1: 0.014 ± 0.003 * KDB1: 0.036 ± 0.005
Clonidine KDB2: 40 ± 20 KDB2: 20 ± 10
DCB: -2.8 DCB: -2.1

KDB1: 9 ± 2 ** KDB1: 51 ± 6
7-OH-PIPAT KDB2: 430 ± 80
DCB: -1.1 DCB: 0

KDB1: 530 ± 50 ** KDB1: 110 ± 10
Quinpirole KDB2: 2700 ± 400
DCB: 0 DCB: -0.8

KDB1: 0.055 ± 0.003 *** KDB1: 0.42 ± 0.03
RO-105824 KDB2: 4000 ± 2000
DCB: -4.3 DCB: 0

Binding parameters from competitive-inhibition experiments of [3H]RX821002 versus NE, DA, clonidine and D2-like receptor ligands in membrane preparations from sheep brain cortex and striatum (Fig. 2). KDB1, KDB2 and DCB values were obtained according to the two-state dimer model (see Materials and Methods and ref. 22). KDB1 and KDB2 (in nM) are expressed as means ± S.E.M. of 3 experiments performed in triplicate. Statistical differences between affinity parameters of cortical versus striatal adrenoceptors were calculated by non-paired, two-tailed Student's t test;

*

p<0.05,

**

p<0.01 and

***

p<0.001.